CTRI/2024/04/066128尚未招募4 期
A prospective, single-arm, single-centre study to evaluate the CT angiographic outcomes after implantation of MeRes100™ Sirolimus Eluting BioResorbable Vascular Scaffold System in coronary artery disease patients. - MeRes100 CIMS-CT Study
Dr Keyur Parikh0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patient who has been implanted with MeRes100 BRS from February 2021 to March 2023.
- •2. Patient has given written informed consent for participation prior to enrolment.
- •3. Patient is willing to undergo all study procedures and follow-up requirements.
排除标准
- •1. Any condition, which in the Investigator’s opinion would preclude safe participation of patient in the study.
- •2. Patient participating in another clinical investigation.
研究者
相似试验
已完成
3 期
A study to assess Efficacy and safety of Ayurvedic Kadha in health and immunity related parameters in mild COVID-19 patients.CTRI/2021/03/032072MARC Laboratories Ltd50
招募中
Unknown
PASSAGE Clinical TrialJPRN-jRCT2032220496Kawahara Kazuo51
进行中（未招募）
3 期
Efficacy and safety of Sirolimus granules twice daily administration in patients with intractuable vascular malformationsIntractable vascular malformationsVascular disordersD054079JPRN-jRCTs031200055Mochizuki Shinji11
已完成
Unknown
OFT-G1-301 StudyCongenital heart diseaseJPRN-jRCT1080224691TEIJIN LIMITED / TEIJIN PHARMA LIMITED30
尚未招募
4 期
A study of Romiplostim Powder for Injection in patientsCTRI/2021/08/035609Intas Pharmaceuticals Limited